{"data":[{"accessionNo":"0001477932-26-006128","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":"29273B500","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-01","reportingPerson":"LHE LNG Holdings LLC","reportingCik":"0002157843","personType":"OO","sharesOwned":254015,"percentOfClass":15.1,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001477932-26-006128","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":"29273B500","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-01","reportingPerson":"ASP Isotopes Inc.","reportingCik":"0001921865","personType":"CO","sharesOwned":254015,"percentOfClass":15.1,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001213900-26-073318","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":"29273B401","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-25","reportingPerson":"Anthony DiGiandomenico","reportingCik":"0001083544","personType":"IN","sharesOwned":196692,"percentOfClass":9.9,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0000898432-25-000936","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-15","reportingPerson":"Anthony DiGiandomenico","reportingCik":"0001083544","personType":"IN","sharesOwned":121622,"percentOfClass":9.99,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001079973-25-001729","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2025-11-14","reportingPerson":"S.H.N. Financial Investments Ltd.","reportingCik":null,"personType":"FI","sharesOwned":35588,"percentOfClass":3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001079973-25-001775","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-14","reportingPerson":"L1 Capital Global Opportunities Master Fund, Ltd.","reportingCik":null,"personType":"FI","sharesOwned":35589,"percentOfClass":3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001213900-25-103810","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock, par value $0.0001","eventDate":"2025-10-23","reportingPerson":"John Carter Lipman","reportingCik":null,"personType":"IN","sharesOwned":115477,"percentOfClass":9.99,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001947975-25-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-16","reportingPerson":"ATW Master Fund V LP","reportingCik":null,"personType":"PN","sharesOwned":116024,"percentOfClass":9.9,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001947975-25-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-16","reportingPerson":"ATW Partners Opportunities Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":116024,"percentOfClass":9.9,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001947975-25-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-16","reportingPerson":"Kerry Propper","reportingCik":null,"personType":"HC,IN","sharesOwned":116024,"percentOfClass":9.9,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"},{"accessionNo":"0001947975-25-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001681682","issuerName":"ENDRA Life Sciences Inc.","ticker":"NDRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-16","reportingPerson":"Antonio Ruiz-Gimenez","reportingCik":null,"personType":"HC,IN","sharesOwned":116024,"percentOfClass":9.9,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/ndra"}],"updatedAt":"2026-11-03T16:47:56.556Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ndra","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}